Case Western Reserve University

Ardent Health Appoints Ambulatory Services and Compliance Leaders

Retrieved on: 
tisdag, maj 21, 2024

Ardent Health today announced the appointments of Ethan Chernin as president of its health services unit and Jason Ehrlinspiel as chief compliance officer.

Key Points: 
  • Ardent Health today announced the appointments of Ethan Chernin as president of its health services unit and Jason Ehrlinspiel as chief compliance officer.
  • “We’re pleased to welcome Ethan and Jason to the Ardent leadership team,” said Marty Bonick , president and CEO of Ardent.
  • With 15 years of healthcare leadership experience, he most recently served as chief population health officer for Healthmap Solutions, a kidney population health management company serving health plans and provider groups.
  • He will lead Ardent’s compliance program with responsibility for driving a culture of ethical business practices, regulatory compliance and integrity across the organization.

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing

Retrieved on: 
torsdag, maj 2, 2024

NEW YORK, May 2, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the peer-reviewed publication of positive data from a National Cancer Institute (NCI)-sponsored, prospective, multicenter clinical validation study assessing the performance of Lucid's EsoGuard® Esophageal DNA Test on samples collected with its EsoCheck® Esophageal Cell Collection Device. This case-control study, led by Case Western Reserve University's Amitabh Chak, M.D., was funded through the NCI's Barrett's Esophagus Translational Research Network (BETRNet), and included renowned investigators from leading academic medical centers, including Case Western Reserve University, Mayo Clinic, Johns Hopkins University, Washington University in St. Louis, University of North Carolina, and Cleveland Clinic. EsoGuard demonstrated unprecedented early precancer detection compared to the gold standard of upper endoscopy (EGD). The manuscript, entitled Multicenter, Prospective Trial of Non-Endoscopic Biomarker-Driven Detection of Barrett's Esophagus And Esophageal Adenocarcinoma, was published in the American Journal of Gastroenterology, the leading clinical journal covering gastroenterology published on behalf of the American College of Gastroenterology (ACG).

Key Points: 
  • EsoGuard demonstrated unprecedented early precancer detection compared to the gold standard of upper endoscopy (EGD).
  • Dr. Aklog concluded, "The publication of the BETRNet study is the culmination of a period of rapid expansion of EsoGuard's clinical evidence base.
  • It represents the second peer-reviewed, and third overall, clinical validation study demonstrating consistently excellent EsoGuard performance.
  • Soon to be released data from a fourth such clinical validation study tells the same story.

Rockefeller Asset Management Expands Fixed Income Capabilities with the Addition of Three Veteran High Yield and Investment Grade Municipal Bond Portfolio Managers

Retrieved on: 
måndag, april 22, 2024

Rockefeller Asset Management (“Rockefeller” or “the Firm”), the asset management arm of Rockefeller Capital Management, today announced the addition of three high yield and investment grade municipal bond professionals: Scott Cottier, Managing Director and Portfolio Manager; Mark DeMitry, Senior Vice President and Portfolio Manager; and Michael Camarella, Senior Vice President and Portfolio Manager.

Key Points: 
  • Rockefeller Asset Management (“Rockefeller” or “the Firm”), the asset management arm of Rockefeller Capital Management, today announced the addition of three high yield and investment grade municipal bond professionals: Scott Cottier, Managing Director and Portfolio Manager; Mark DeMitry, Senior Vice President and Portfolio Manager; and Michael Camarella, Senior Vice President and Portfolio Manager.
  • The move expands the firm’s capabilities providing differentiated investment solutions within its Fixed Income business, which currently manages approximately $5 billion on behalf of investors.
  • They will report to Alex Petrone, Director of Fixed Income, and support the expansion of Rockefeller Asset Management’s active fixed income investment solutions, including launching new high yield municipal credit investment strategies and vehicles.
  • The addition of Cottier, DeMitry, and Camarella also introduces Rockefeller to the Rochester market, where they will be based.

Fay Cobb Payton to Deliver Keynote at 2024 Minority Serving - Cyberinfrastructure Consortium Annual Meeting

Retrieved on: 
torsdag, april 25, 2024

WASHINGTON, April 25, 2024 /PRNewswire/ -- Fay Cobb Payton — award-winning researcher, international speaker, and entrepreneur — will deliver the closing keynote at the 2024 Annual Meeting for the Minority Serving - Cyberinfrastructure Consortium (MS-CC), May 29-31, in Washington, D.C.

Key Points: 
  • WASHINGTON, April 25, 2024 /PRNewswire/ -- Fay Cobb Payton — award-winning researcher, international speaker, and entrepreneur — will deliver the closing keynote at the 2024 Annual Meeting for the Minority Serving - Cyberinfrastructure Consortium (MS-CC), May 29-31, in Washington, D.C.
  • The keynote, "The Importance of Inclusive Cyberinfrastructure," will be held at 11:45 a.m.
  • Payton is a visiting scholar of inclusive innovation at Rutgers University - Newark and a professor emerita of information technology and analytics at North Carolina State University.
  • Previously, Payton completed a rotation as program director at the National Science Foundation (NSF), where she initiated the CISE Minority Serving Institution Research Expansion Program, and her tenure was recognized with the NSF Director's Award.

Former Regulatory Examiner and Senior Risk Advisor Vincent Coe joins Asurity Advisors™️

Retrieved on: 
tisdag, april 23, 2024

WASHINGTON, April 23, 2024 /PRNewswire/ -- Asurity Advisors, LLC, a leading provider of regulatory risk and compliance consulting services to the mortgage and financial services industries, announced today that seasoned regulator, advisor, and regulatory risk consultant, Vincent Coe has joined the organization as a Director.

Key Points: 
  • WASHINGTON, April 23, 2024 /PRNewswire/ -- Asurity Advisors, LLC, a leading provider of regulatory risk and compliance consulting services to the mortgage and financial services industries, announced today that seasoned regulator, advisor, and regulatory risk consultant, Vincent Coe has joined the organization as a Director.
  • Vince most recently served as leader of a boutique advisory firm, assisting clients with matters spanning enterprise risk management, risk reporting, dashboarding and business planning, UDAAP, and Fair Lending.
  • "We are thrilled to have Vince as the newest member of our growing Asurity Advisors team," said Grace Brasington, Senior Managing Director.
  • Asurity Advisors services include: CMS Reviews, Fair and Responsible Banking, CRA, Crossing the $10 Billion Threshold, Fintech Compliance, Enterprise Risk Management, and Operational Reviews/Process Improvement.

University of Medicine and Health Sciences Celebrates Historic Match Day for Graduating Students

Retrieved on: 
måndag, april 22, 2024

NEW YORK, April 22, 2024 /PRNewswire-PRWeb/ -- The University of Medicine and Health Sciences, (UMHS), a small, mission-driven medical school with a commitment to student support and a legacy of successful residency placements in the United States and Canada, celebrated one of its most successful Match Days in history. A remarkable 91% of first-time applicants secured residency placements, with graduating students earning positions in competitive programs across 14 medical specialties spanning 27 states, Puerto Rico, and Canada.

Key Points: 
  • In a message to students, UMHS President Warren Ross praised the school's historic 2024 Match results.
  • Graduating students secured residencies in highly competitive programs and will continue their training at esteemed teaching hospitals such as Case Western in Ohio and the University of Massachusetts Chan Medical School.
  • UMHS students matched into all six core specialties, including family medicine, internal medicine, obstetrics & gynecology, pediatrics, psychiatry, and surgery, as well as eight specialty fields, including anesthesiology, child neurology, diagnostic radiology, emergency medicine, neurology, pathology, and physical medicine and rehabilitation.
  • To learn more about the UMHS Class of 2024 Match Day and to see the complete 2024 Match results please visit https://www.umhs-sk.org/match-results .

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

Retrieved on: 
torsdag, mars 21, 2024

Those interested in attending the event, which will be held virtually TODAY, March 21, 2024 at 1PM ET, may register here.

Key Points: 
  • Those interested in attending the event, which will be held virtually TODAY, March 21, 2024 at 1PM ET, may register here.
  • will focus on the current treatment options in the infertility services market, including Femasys’ FDA-authorized FemaSeed device for intratubal insemination.
  • Ms. Lee-Sepsick is the founder of Femasys and has nearly three decades of experience as a senior executive in the medical technology industry.
  • She is the lead inventor of the technologies at Femasys and remains committed to advancing much needed technology in women’s health.

Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024

Retrieved on: 
onsdag, mars 13, 2024

ATLANTA, March 13, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting the significant unmet needs for women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic products, announces it will participate in a Fireside Chat with Jones Trading Analyst Catherine Novack to discuss the current treatment landscape for infertility treatment in women. Those interested in attending the event, which will be held virtually on March 21, 2024 at 1PM ET, may register here.

Key Points: 
  • Those interested in attending the event, which will be held virtually on March 21, 2024 at 1PM ET, may register here.
  • will focus on the current treatment options in the infertility services market, including Femasys’ FDA-authorized FemaSeed device for intratubal insemination.
  • Ms. Lee-Sepsick is the founder of Femasys and has nearly three decades of experience as a senior executive in the medical technology industry.
  • She is the lead inventor of the technologies at Femasys and remains committed to advancing much needed technology in women’s health.

Symetra Appoints Soraya Alexander and April Galda Joyce to Board of Directors

Retrieved on: 
torsdag, april 4, 2024

Symetra Financial Corporation today announced the appointments of Soraya Alexander and April Galda Joyce to its board of directors.

Key Points: 
  • Symetra Financial Corporation today announced the appointments of Soraya Alexander and April Galda Joyce to its board of directors.
  • View the full release here: https://www.businesswire.com/news/home/20240404333545/en/
    Soraya Alexander joins Symetra Financial Corporation's board of directors.
  • (Photo: Business Wire)
    “We are very pleased to welcome Soraya and April to the Symetra board.
  • Ms. Galda Joyce received a Bachelor of Science in management from Case Western Reserve University.

Lincoln Electric Appoints Michele R. Kuhrt as Chief Transformation Officer

Retrieved on: 
onsdag, april 3, 2024

Lincoln Electric Holdings, Inc. (Nasdaq: LECO) (“Company”), announced today that Michele R. Kuhrt has been appointed as Executive Vice President, Chief Transformation Officer (CTO), effective April 8, 2024.

Key Points: 
  • Lincoln Electric Holdings, Inc. (Nasdaq: LECO) (“Company”), announced today that Michele R. Kuhrt has been appointed as Executive Vice President, Chief Transformation Officer (CTO), effective April 8, 2024.
  • She will continue to serve as a member of the executive leadership team and report to Steven B. Hedlund, President and Chief Executive Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240403151965/en/
    Michele Kuhrt appointed as Executive Vice President, Chief Transformation Officer at Lincoln Electric.
  • “I am excited to appoint Michele as our first Chief Transformation Officer,” stated Mr. Hedlund.